3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
9
Pancreatic Neoplasms
8
Rectal Neoplasms
5
Urinary Bladder Neoplasms
4
Stomach Neoplasms
4
Colonic Neoplasms
3
Adenocarcinoma Of Esophagus
3
Squamous Cell Carcinoma of Head and Neck
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Clinical Stage I Gastric Cancer AJCC v8
2
Cholangiocarcinoma
2
Appendiceal Neoplasms
2
Anus Neoplasms
2
Uterine Neoplasms
1
Tongue Neoplasms
1
Sinonasal undifferentiated carcinoma
1
Salivary Gland Neoplasms
1
Peritoneal Neoplasms
1
Paranasal Sinus Neoplasms
1
Pancreatic Intraductal Neoplasms
1
Pancreatic Adenocarcinoma
1
PRETEXT I Hepatoblastoma
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Metastatic Small Intestinal Adenocarcinoma
1
Lymphoid Interstitial Pneumonia
1
Laryngeal Neoplasms
1
Interventions
pembrolizumab
137
Nivolumab
116
Ipilimumab
68
Cyclophosphamide
33
Specimen Handling
31
Magnetic Resonance Spectroscopy
28
trametinib
23
binimetinib
22
fludarabine
21
Interleukin-2
20
dabrafenib
19
relatlimab
17
encorafenib
17
Biopsy
17
CTLA-4 Antigen
16
cemiplimab
15
atezolizumab
15
aldesleukin
15
Radiosurgery
15
fludarabine phosphate
14
Opdualag
14
Radiotherapy
11
lenvatinib
10
Blood Specimen Collection
10
lifileucel
9
Paclitaxel
8
Cisplatin
8
Bevacizumab
8
spartalizumab
7
cobimetinib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
dehydroftorafur
×
1 year
×
Clear all
No trials found.